Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy-Reference-Cited by-同舟云学术

Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy

Published:1984-12 Issue:4 Volume:58 Page:689-696
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Boccadoro Mario,Gavarotti Paolo,Fossati Giorgio,Pileri Alessandro,Marmont Filippo,Neretto Giorgio,Gallamini Andrea,Volta Carla,Tribalto Maurizio,Testa Maria G.,Amadori Sergio,Mandelli Franco,Durie Brian G. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1984.tb06116.x/fullpdf

Reference22 articles.

1. Unmaintained remissions in multiple myeloma

2. Total body irradiation for myelomatosis.

3. Kinetics of circulating B lymphocytes in human myeloma

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma;Frontiers in Immunology;2023-11-15

2. Amino Acid and Proliferation PET/CT for the Diagnosis of Multiple Myeloma;Frontiers in Nuclear Medicine;2022-01-06

3. Genomic Instability in Multiple Myeloma;Trends in Cancer;2020-10

4. Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma;Blood Advances;2020-05-22

5. Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review);International Journal of Oncology;2016-05-11